CN101684500A - 测定结肠癌 - Google Patents

测定结肠癌 Download PDF

Info

Publication number: CN101684500A
Authority: CN; China
Prior art keywords: seq; gene; people; expression; molectron
Prior art date: 2002-03-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

CN200910175739A

Other languages

English (en)

Chinese (zh)

Inventor

Y·王

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ortho Clinical Diagnostics Inc

Original Assignee

Ortho Clinical Diagnostics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-29

Filing date

2003-03-29

Publication date

2010-03-31

2003-03-29 Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc

2010-03-31 Publication of CN101684500A publication Critical patent/CN101684500A/zh

Status Pending legal-status Critical Current

Links

206010009944 Colon cancer Diseases 0.000 title claims abstract description 30
208000001333 Colorectal Neoplasms Diseases 0.000 title claims abstract description 29
108090000623 proteins and genes Proteins 0.000 claims abstract description 133
230000014509 gene expression Effects 0.000 claims abstract description 73
238000002493 microarray Methods 0.000 claims abstract description 24
206010028980 Neoplasm Diseases 0.000 claims description 27
201000010989 colorectal carcinoma Diseases 0.000 claims description 26
239000002299 complementary DNA Substances 0.000 claims description 24
238000012360 testing method Methods 0.000 claims description 17
238000003745 diagnosis Methods 0.000 claims description 16
238000011282 treatment Methods 0.000 claims description 13
239000000463 material Substances 0.000 claims description 12
201000011510 cancer Diseases 0.000 claims description 10
230000000295 complement effect Effects 0.000 claims description 8
210000001072 colon Anatomy 0.000 claims description 7
239000011159 matrix material Substances 0.000 claims description 7
150000007523 nucleic acids Chemical group 0.000 claims description 7
230000001105 regulatory effect Effects 0.000 claims description 7
239000002773 nucleotide Substances 0.000 claims description 5
125000003729 nucleotide group Chemical group 0.000 claims description 5
238000004519 manufacturing process Methods 0.000 claims description 4
208000029742 colonic neoplasm Diseases 0.000 claims description 3
102000000820 Enterotoxin Receptors Human genes 0.000 claims description 2
108010001687 Enterotoxin Receptors Proteins 0.000 claims description 2
239000000427 antigen Substances 0.000 claims description 2
108091007433 antigens Proteins 0.000 claims description 2
102000036639 antigens Human genes 0.000 claims description 2
239000003153 chemical reaction reagent Substances 0.000 claims description 2
238000010208 microarray analysis Methods 0.000 claims description 2
108091034117 Oligonucleotide Proteins 0.000 claims 1
238000000034 method Methods 0.000 abstract description 38
239000000523 sample Substances 0.000 description 53
108020004414 DNA Proteins 0.000 description 50
230000002068 genetic effect Effects 0.000 description 30
108020004635 Complementary DNA Proteins 0.000 description 23
238000010804 cDNA synthesis Methods 0.000 description 23
210000004027 cell Anatomy 0.000 description 23
230000008859 change Effects 0.000 description 15
210000001519 tissue Anatomy 0.000 description 13
201000010099 disease Diseases 0.000 description 10
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
108020004999 messenger RNA Proteins 0.000 description 10
108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
238000005516 engineering process Methods 0.000 description 9
238000005259 measurement Methods 0.000 description 9
102000004169 proteins and genes Human genes 0.000 description 9
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
238000004458 analytical method Methods 0.000 description 8
238000002474 experimental method Methods 0.000 description 8
238000000370 laser capture micro-dissection Methods 0.000 description 8
238000006243 chemical reaction Methods 0.000 description 6
108090000765 processed proteins & peptides Proteins 0.000 description 6
238000004393 prognosis Methods 0.000 description 6
238000009396 hybridization Methods 0.000 description 5
239000003550 marker Substances 0.000 description 5
210000005259 peripheral blood Anatomy 0.000 description 5
239000011886 peripheral blood Substances 0.000 description 5
210000002826 placenta Anatomy 0.000 description 5
239000002243 precursor Substances 0.000 description 5
206010006187 Breast cancer Diseases 0.000 description 4
208000026310 Breast neoplasm Diseases 0.000 description 4
102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 4
108700005075 Regulator Genes Proteins 0.000 description 4
230000003321 amplification Effects 0.000 description 4
238000013461 design Methods 0.000 description 4
238000009826 distribution Methods 0.000 description 4
230000000694 effects Effects 0.000 description 4
239000005357 flat glass Substances 0.000 description 4
238000003199 nucleic acid amplification method Methods 0.000 description 4
238000012340 reverse transcriptase PCR Methods 0.000 description 4
208000024891 symptom Diseases 0.000 description 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
238000013459 approach Methods 0.000 description 3
230000002596 correlated effect Effects 0.000 description 3
230000000875 corresponding effect Effects 0.000 description 3
210000002919 epithelial cell Anatomy 0.000 description 3
239000000284 extract Substances 0.000 description 3
210000004907 gland Anatomy 0.000 description 3
238000011534 incubation Methods 0.000 description 3
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Substances N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 3
210000004400 mucous membrane Anatomy 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
230000008569 process Effects 0.000 description 3
210000002966 serum Anatomy 0.000 description 3
102100037965 60S ribosomal protein L21 Human genes 0.000 description 2
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
108020004394 Complementary RNA Proteins 0.000 description 2
102000029792 Desmoplakin Human genes 0.000 description 2
108091000074 Desmoplakin Proteins 0.000 description 2
102100032822 Homeodomain-interacting protein kinase 1 Human genes 0.000 description 2
101001066404 Homo sapiens Homeodomain-interacting protein kinase 1 Proteins 0.000 description 2
206010061535 Ovarian neoplasm Diseases 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
230000002759 chromosomal effect Effects 0.000 description 2
239000003184 complementary RNA Substances 0.000 description 2
239000013068 control sample Substances 0.000 description 2
238000005520 cutting process Methods 0.000 description 2
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
238000004043 dyeing Methods 0.000 description 2
YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
230000008014 freezing Effects 0.000 description 2
238000007710 freezing Methods 0.000 description 2
230000030279 gene silencing Effects 0.000 description 2
238000012226 gene silencing method Methods 0.000 description 2
229940125396 insulin Drugs 0.000 description 2
239000006101 laboratory sample Substances 0.000 description 2
210000004185 liver Anatomy 0.000 description 2
238000012775 microarray technology Methods 0.000 description 2
239000000203 mixture Substances 0.000 description 2
238000000329 molecular dynamics simulation Methods 0.000 description 2
239000013610 patient sample Substances 0.000 description 2
238000000746 purification Methods 0.000 description 2
238000004445 quantitative analysis Methods 0.000 description 2
108090000327 ribosomal protein L21 Proteins 0.000 description 2
210000000952 spleen Anatomy 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
238000013518 transcription Methods 0.000 description 2
230000035897 transcription Effects 0.000 description 2
238000012546 transfer Methods 0.000 description 2
238000005406 washing Methods 0.000 description 2
WZUVPPKBWHMQCE-XJKSGUPXSA-N (+)-haematoxylin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-XJKSGUPXSA-N 0.000 description 1
101150033839 4 gene Proteins 0.000 description 1
101150039504 6 gene Proteins 0.000 description 1
102100033936 AP-3 complex subunit beta-1 Human genes 0.000 description 1
101710165439 AP-3 complex subunit beta-1 Proteins 0.000 description 1
206010001167 Adenocarcinoma of colon Diseases 0.000 description 1
108060000903 Beta-catenin Proteins 0.000 description 1
102000015735 Beta-catenin Human genes 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
241000252983 Caecum Species 0.000 description 1
101100422242 Caenorhabditis elegans sqv-7 gene Proteins 0.000 description 1
102000003846 Carbonic anhydrases Human genes 0.000 description 1
108090000209 Carbonic anhydrases Proteins 0.000 description 1
108010022366 Carcinoembryonic Antigen Proteins 0.000 description 1
206010007275 Carcinoid tumour Diseases 0.000 description 1
229920000742 Cotton Polymers 0.000 description 1
102100021934 Cyclin-D1-binding protein 1 Human genes 0.000 description 1
102100028843 DNA mismatch repair protein Mlh1 Human genes 0.000 description 1
102100034157 DNA mismatch repair protein Msh2 Human genes 0.000 description 1
102100021147 DNA mismatch repair protein Msh6 Human genes 0.000 description 1
241001269238 Data Species 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102100027297 Fatty acid 2-hydroxylase Human genes 0.000 description 1
102000016359 Fibronectins Human genes 0.000 description 1
108010067306 Fibronectins Proteins 0.000 description 1
108700039691 Genetic Promoter Regions Proteins 0.000 description 1
WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Natural products C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 1
101000897488 Homo sapiens Cyclin-D1-binding protein 1 Proteins 0.000 description 1
101001134036 Homo sapiens DNA mismatch repair protein Msh2 Proteins 0.000 description 1
101000968658 Homo sapiens DNA mismatch repair protein Msh6 Proteins 0.000 description 1
101000937693 Homo sapiens Fatty acid 2-hydroxylase Proteins 0.000 description 1
101000738901 Homo sapiens PMS1 protein homolog 1 Proteins 0.000 description 1
101000685275 Homo sapiens Protein sel-1 homolog 1 Proteins 0.000 description 1
101000825182 Homo sapiens Transcription factor Spi-B Proteins 0.000 description 1
101100483382 Homo sapiens UBE2J1 gene Proteins 0.000 description 1
101150062179 II gene Proteins 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
208000005016 Intestinal Neoplasms Diseases 0.000 description 1
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
229910015837 MSH2 Inorganic materials 0.000 description 1
208000032818 Microsatellite Instability Diseases 0.000 description 1
108010074346 Mismatch Repair Endonuclease PMS2 Proteins 0.000 description 1
102100037480 Mismatch repair endonuclease PMS2 Human genes 0.000 description 1
108010026664 MutL Protein Homolog 1 Proteins 0.000 description 1
ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
108091028043 Nucleic acid sequence Proteins 0.000 description 1
101710157860 Oxydoreductase Proteins 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
102100037482 PMS1 protein homolog 1 Human genes 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
108700001094 Plant Genes Proteins 0.000 description 1
102100023159 Protein sel-1 homolog 1 Human genes 0.000 description 1
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
101710137500 T7 RNA polymerase Proteins 0.000 description 1
108091023040 Transcription factor Proteins 0.000 description 1
102000040945 Transcription factor Human genes 0.000 description 1
102100022281 Transcription factor Spi-B Human genes 0.000 description 1
102100024860 Ubiquitin-conjugating enzyme E2 J1 Human genes 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000009471 action Effects 0.000 description 1
238000007605 air drying Methods 0.000 description 1
230000001476 alcoholic effect Effects 0.000 description 1
230000000735 allogeneic effect Effects 0.000 description 1
108010061314 alpha-L-Fucosidase Proteins 0.000 description 1
230000003322 aneuploid effect Effects 0.000 description 1
208000036878 aneuploidy Diseases 0.000 description 1
101150036080 at gene Proteins 0.000 description 1
239000012472 biological sample Substances 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
238000004422 calculation algorithm Methods 0.000 description 1
208000002458 carcinoid tumor Diseases 0.000 description 1
210000004534 cecum Anatomy 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
208000029664 classic familial adenomatous polyposis Diseases 0.000 description 1
238000010367 cloning Methods 0.000 description 1
238000007621 cluster analysis Methods 0.000 description 1
201000010897 colon adenocarcinoma Diseases 0.000 description 1
230000000112 colonic effect Effects 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
238000004590 computer program Methods 0.000 description 1
238000013016 damping Methods 0.000 description 1
238000007405 data analysis Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
239000012502 diagnostic product Substances 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 1
238000010195 expression analysis Methods 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000012530 fluid Substances 0.000 description 1
239000011888 foil Substances 0.000 description 1
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
238000003167 genetic complementation Methods 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
230000036541 health Effects 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
210000003917 human chromosome Anatomy 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
201000002313 intestinal cancer Diseases 0.000 description 1
239000007788 liquid Substances 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
238000007885 magnetic separation Methods 0.000 description 1
230000003211 malignant effect Effects 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
239000012528 membrane Substances 0.000 description 1
210000002500 microbody Anatomy 0.000 description 1
230000009456 molecular mechanism Effects 0.000 description 1
230000002969 morbid Effects 0.000 description 1
210000004877 mucosa Anatomy 0.000 description 1
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
238000003499 nucleic acid array Methods 0.000 description 1
238000002966 oligonucleotide array Methods 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
238000005457 optimization Methods 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
230000007170 pathology Effects 0.000 description 1
230000000505 pernicious effect Effects 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
238000002203 pretreatment Methods 0.000 description 1
239000000047 product Substances 0.000 description 1
238000001959 radiotherapy Methods 0.000 description 1
238000003753 real-time PCR Methods 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
238000011084 recovery Methods 0.000 description 1
239000003161 ribonuclease inhibitor Substances 0.000 description 1
108091092562 ribozyme Proteins 0.000 description 1
238000010187 selection method Methods 0.000 description 1
FZHAPNGMFPVSLP-UHFFFAOYSA-N silanamine Chemical compound [SiH3]N FZHAPNGMFPVSLP-UHFFFAOYSA-N 0.000 description 1
229910052710 silicon Inorganic materials 0.000 description 1
239000010703 silicon Substances 0.000 description 1
238000011524 similarity measure Methods 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 1
239000007921 spray Substances 0.000 description 1
238000007619 statistical method Methods 0.000 description 1
238000000528 statistical test Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000000758 substrate Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Analytical Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

CN200910175739A 2002-03-29 2003-03-29 测定结肠癌 Pending CN101684500A (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US36868702P	2002-03-29	2002-03-29
US60/368687		2002-03-29

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CNA031378714A Division CN1502989A (zh)	2002-03-29	2003-03-29	测定结肠癌

Publications (1)

Publication Number	Publication Date
CN101684500A true CN101684500A (zh)	2010-03-31

Family

ID=28675528

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
CNA031378714A Pending CN1502989A (zh)	2002-03-29	2003-03-29	测定结肠癌
CN200910175739A Pending CN101684500A (zh)	2002-03-29	2003-03-29	测定结肠癌

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
CNA031378714A Pending CN1502989A (zh)	2002-03-29	2003-03-29	测定结肠癌

Country Status (10)

Country	Link
US (1)	US20030186303A1 (fr)
EP (1)	EP1355151A3 (fr)
JP (2)	JP4354725B2 (fr)
KR (1)	KR100984996B1 (fr)
CN (2)	CN1502989A (fr)
AR (1)	AR039211A1 (fr)
AU (1)	AU2003203561A1 (fr)
BR (1)	BR0303012A (fr)
CA (1)	CA2422305C (fr)
MX (1)	MXPA03002863A (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102586423A (zh) *	2011-12-27	2012-07-18	盛司潼	一种检测结直肠癌易感基因的方法及试剂盒
CN102586420A (zh) *	2011-12-27	2012-07-18	盛司潼	一种检测乳腺癌易感基因的方法及试剂盒
CN115678994A (zh) *	2022-01-27	2023-02-03	上海爱谱蒂康生物科技有限公司	一种生物标志物组合、含其的试剂及其应用

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2475769C (fr) *	2003-08-28	2018-12-11	Veridex, Llc	Pronostic du cancer colo-rectal
WO2005066363A2 (fr) *	2004-01-09	2005-07-21	Medigen Biotechnology Corporation	Gene mg20 specifique du cancer
CA2610709A1 (fr) *	2005-06-06	2006-12-14	Genentech, Inc.	Nouvelles disruptions geniques, nouvelles compositions et nouveaux procedes s'y rapportant
JP5237817B2 (ja) *	2005-10-21	2013-07-17	ジーンニュースインコーポレーティッド	バイオマーカー産物レベルを疾患に相関させるための方法および装置
US20080058432A1 (en) *	2006-03-03	2008-03-06	Yixin Wang	Molecular assay to predict recurrence of Duke's B colon cancer
EP2644713B1 (fr) *	2007-10-23	2018-07-04	Clinical Genomics Pty Ltd	Procédé permettant de diagnostiquer des néoplasmes - II
EP2169078A1 (fr)	2008-09-26	2010-03-31	Fundacion Gaiker	Procédés et kits pour le diagnostic et la stratification du cancer colorectal
WO2013092960A1 (fr)	2011-12-22	2013-06-27	Fundacion Gaiker	Procédés et kits destinés au diagnostic du cancer colorectal

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US635152A (en) *	1899-06-05	1899-10-17	Melancthon S Shotwell	Car-body bolster.
US6275814B1 (en) *	1996-11-27	2001-08-14	Investment Strategies Network	Investment portfolio selection system and method
US6003018A (en) *	1998-03-27	1999-12-14	Michaud Partners Llp	Portfolio optimization by means of resampled efficient frontiers
US6350578B1 (en) *	1999-06-25	2002-02-26	The Regents Of The University Of California	Method of quantitating dsDNA
US6175824B1 (en) *	1999-07-14	2001-01-16	Chi Research, Inc.	Method and apparatus for choosing a stock portfolio, based on patent indicators

2003
- 2003-03-21 US US10/394,382 patent/US20030186303A1/en not_active Abandoned
- 2003-03-28 CA CA2422305A patent/CA2422305C/fr not_active Expired - Fee Related
- 2003-03-28 BR BR0303012-1A patent/BR0303012A/pt not_active IP Right Cessation
- 2003-03-28 AU AU2003203561A patent/AU2003203561A1/en not_active Abandoned
- 2003-03-29 CN CNA031378714A patent/CN1502989A/zh active Pending
- 2003-03-29 CN CN200910175739A patent/CN101684500A/zh active Pending
- 2003-03-29 KR KR1020030019815A patent/KR100984996B1/ko not_active Expired - Fee Related
- 2003-03-31 EP EP03252024A patent/EP1355151A3/fr not_active Withdrawn
- 2003-03-31 MX MXPA03002863A patent/MXPA03002863A/es active IP Right Grant
- 2003-03-31 JP JP2003094744A patent/JP4354725B2/ja not_active Expired - Fee Related
- 2003-04-01 AR ARP030101132A patent/AR039211A1/es not_active Application Discontinuation
2009
- 2009-03-31 JP JP2009086981A patent/JP2009153521A/ja active Pending

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102586423A (zh) *	2011-12-27	2012-07-18	盛司潼	一种检测结直肠癌易感基因的方法及试剂盒
CN102586420A (zh) *	2011-12-27	2012-07-18	盛司潼	一种检测乳腺癌易感基因的方法及试剂盒
CN115678994A (zh) *	2022-01-27	2023-02-03	上海爱谱蒂康生物科技有限公司	一种生物标志物组合、含其的试剂及其应用

Also Published As

Publication number	Publication date
EP1355151A3 (fr)	2004-08-25
JP2009153521A (ja)	2009-07-16
AU2003203561A1 (en)	2003-10-23
CA2422305A1 (fr)	2003-09-29
KR20030078801A (ko)	2003-10-08
AR039211A1 (es)	2005-02-09
CA2422305C (fr)	2013-07-30
JP4354725B2 (ja)	2009-10-28
MXPA03002863A (es)	2004-08-11
JP2003325191A (ja)	2003-11-18
EP1355151A2 (fr)	2003-10-22
CN1502989A (zh)	2004-06-09
BR0303012A (pt)	2004-09-08
US20030186303A1 (en)	2003-10-02
KR100984996B1 (ko)	2010-10-04

Legal Events

Date	Code	Title	Description
2010-03-31	C06	Publication
2010-03-31	PB01	Publication
2010-05-12	C10	Entry into substantive examination
2010-05-12	SE01	Entry into force of request for substantive examination
2013-06-19	C02	Deemed withdrawal of patent application after publication (patent law 2001)
2013-06-19	WD01	Invention patent application deemed withdrawn after publication	Application publication date: 20100331

Publication	Publication Date	Title
US10889865B2 (en)	2021-01-12	Thyroid tumors identified
CA2442820A1 (fr)	2002-10-10	Etablissement de profils d'expression genique dans un microreseau dans un adenocarcinome a cellules claires, pronostic et identification de cible medicamenteuse
US20040241725A1 (en)	2004-12-02	Lung cancer detection
KR100984996B1 (ko)	2010-10-04	결장직장암의 검사방법
CN101603092B (zh)	2012-11-07	评估结肠直肠癌
AU2016377391B2 (en)	2022-09-01	Triage biomarkers and uses therefor
WO2007135174A1 (fr)	2007-11-29	Modèle d'expression génique prédictif pour le cancer colorectal
US20070298419A1 (en)	2007-12-27	K-Ras Oligonucleotide Microarray and Method for Detecting K-Ras Mutations Employing the Same
CN1856573A (zh)	2006-11-01	用于神经母细胞瘤预后诊断的微阵列和神经母细胞瘤预后诊断方法
AU2004205270B2 (en)	2009-01-22	Colorectal cancer prognostics
KR20210122017A (ko)	2021-10-08	색소침착 피부 타입 판단용 유전자 다형성 마커 및 이의 용도
KR101774275B1 (ko)	2017-09-04	고추의 여교배 육종을 위한 단일염기다형성 마커 세트 및 이의 용도
KR20220141658A (ko)	2022-10-20	피부색 판단용 유전자 다형성 마커 및 이의 용도
CN1985004A (zh)	2007-06-20	监测丝状真菌细胞中基因表达的方法
CA3067730C (fr)	2025-11-25	Procedes de detection de dysglobulinemie plasmocytaire
KR101141546B1 (ko)	2012-05-03	Ａｎｋｒｄ15, ｈｐｄ, ｐｓｍｄ9, ｗｄｒ66, ｇｐｃ6, ｐａｘ9, ｌｒｒｃ28, ｔｎｓ4, ａｘｌ, 및 ｈｎｒｐｕｌ1 유전자로부터 유래된 단일염기다형을 포함하는 폴리뉴클레오티드, 이를 포함하는 마이크로어레이 및 진단키트, 및 이를 이용한 분석방법
ten Asbroek et al.	2002	Ribonuclease H1 maps to chromosome 2 and has at least three pseudogene loci in the human genome
JP2002112799A (ja)	2002-04-16	癌疾患の予後判定法
CA3067730A1 (fr)	2019-01-24	Procedes de detection de dysglobulinemie plasmocytaire
KR20220137382A (ko)	2022-10-12	주름 피부 타입 판단용 유전자 다형성 마커 및 이의 용도
KR20220141659A (ko)	2022-10-20	피부색 판단용 유전자 다형성 마커 및 이의 용도
KR101139360B1 (ko)	2012-04-26	Ｐｒｋｃｉ, ｍａｐｋ10, ｓｐｐ1, ｉｑｇａｐ2, ｆｇｆｒ4, ｎｏｔｃｈ4, ｈｌａ-ｄｒａ, ｈｌａ-ｄｏａ, ｔｈｂｓ2, ｄｆｎａ5, ｔｂｘａｓ1, ｔｎｋｓ, ｃｄｈ17, ｕｂｒ5, ｋｉａａ0196, 및 ｎｓｍｃｅ2 유전자로부터 유래된 단일염기다형을 포함하는 폴리뉴클레오티드, 이를 포함하는 마이크로어레이 및 진단키트, 및 이를 이용한 분석방법
US20070059714A1 (en)	2007-03-15	Detection of presence and antibiotic susceptibility of enterococci
KR20230036927A (ko)	2023-03-15	아토피 피부염의 발병 위험도 예측 또는 진단을 위한 정보제공 방법
KR20130100640A (ko)	2013-09-11	복부비만 예측용 ｓｎｐ 마커 및 이의 용도

CN101684500A - 测定结肠癌 - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (2)

Related Parent Applications (1)

Publications (1)

Family

ID=28675528

Family Applications (2)

Family Applications Before (1)

Country Status (10)

Cited By (3)

Families Citing this family (8)

Family Cites Families (5)

Cited By (3)

Also Published As

Similar Documents

Legal Events